نتائج البحث

المصدر: Armand, P, Janssens, A, Gritti, G, Radford, J, Timmerman, J, Pinto, A, Mercadal Vilchez, S, Johnson, P, Cunningham, D, Leonard, J P, Rodig, S J, Martín-Regueira, P, Sumbul, A, Samakoglu, S, Tang, H & Ansell, S M 2021, ' Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma ', Blood, vol. 137, no. 5, pp. 637-645 . https://doi.org/10.1182/blood.2019004753Test

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Immunology, Programmed Cell Death 1 Receptor, Follicular lymphoma, Salvage therapy, Phases of clinical research, Kaplan-Meier Estimate, Biochemistry, Antineoplastic Agents, Immunological, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Biomarkers, Tumor, Tumor Microenvironment, Humans, Progression-free survival, Antineoplastic Agents, Alkylating, Lymphoma, Follicular, Aged, CD20, Salvage Therapy, Manchester Cancer Research Centre, biology, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Gene Expression Profiling, Hazard ratio, Cell Biology, Hematology, Middle Aged, medicine.disease, Progression-Free Survival, Neoplasm Proteins, Nivolumab, biology.protein, Female, business, Rituximab, Follow-Up Studies

وصف الملف: text

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca62b92f3b8ac9fb9fccbb61f4dabbdTest
https://pubmed.ncbi.nlm.nih.gov/33538800Test

10

High prevalence of human T-cell leukemia virus type-1b genotype among blood donors in Gabon, Central Africa

المؤلفون: Jophrette Mireille Ntsame‐Ndong, Antoine Gessain, Olivier Cassar, Manoushka Toumbiri, Antony Idam Mamimandjiami, Jill-Léa Ramassamy, Augustin Mouinga-Ondémé, Abdoulaye Diané, Calixte Bengone

المساهمون: Epidémiologie et Physiopathologie des Virus Oncogènes / Oncogenic Virus Epidemiology and Pathophysiology (EPVO (UMR_3569 / U-Pasteur_3)), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre International de Recherches Médicales de Franceville (CIRMF), Ecole Doctorale Régionale d’Afrique Centrale, Centre National de Transfusion Sanguine [Libreville, Gabon] (CNTS), This study received funding from the CNRS (UMR 3569) (AG), the Institut Pasteur, France (AG), and through the 'Investissement dʼAvenir' as part of a French 'Laboratoire dʼExcellence' (LabEx) research program: Integrative Biology of Emerging Infectious Diseases (ANR10-LBX-62 IBEID) (AG). JLR received financial support from the European Union (FOOD/2016/379-660)., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)

المصدر: Transfusion
Transfusion, 2020, 60 (7), pp.1483-1491. ⟨10.1111/trf.15838⟩
Transfusion, Wiley, 2020, 60 (7), pp.1483-1491. ⟨10.1111/trf.15838⟩

مصطلحات موضوعية: Adult, Male, Veterinary medicine, Adolescent, Genotype, Immunology, Blood Donors, Enzyme-Linked Immunosorbent Assay, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, Blood donations, 0302 clinical medicine, law, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Prevalence, Immunology and Allergy, Medicine, Humans, Gabon, Antigens, Viral, Polymerase chain reaction, Human T-lymphotropic virus 1, High prevalence, biology, business.industry, Transmission (medicine), Central africa, Hematology, Middle Aged, HTLV-I Infections, 3. Good health, Human T cell leukemia virus, Donor Infectious Disease Testing, biology.protein, Female, Antibody, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181e3b036c030370111dcd3480e9c0b1Test
https://pubmed.ncbi.nlm.nih.gov/32415686Test

تنقيح النتائج